GLP-1 Drugs Linked To Better Breast Cancer Outcomes
-
May 13, 2026
- SpanishHealthDayTV HealthDay Reporter
In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.
Health News is provided as a service to Cayucos Pharmacy site users by HealthDay. Cayucos Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.
